MILLENNIUM MANAGEMENT LLC

Position in GRFS — Grifols SA

CIK 1273087 NEW YORK, NY

Back to GRFS Full portfolio

Position in GRFS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$30,939,132

-$9,205,234 QoQ

Shares Held

4,369,934

-12.7% QoQ

Ownership

0.642%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

of 164 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in GRFS Over Time

Shares Held

Position Value (USD)

Derivatives in GRFS

reported options exposure · as of Mar 31, 2025

CallValue

$255,960

CallShares

36,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

MILLENNIUM MANAGEMENT LLC holds $1,658,702,438 across 15 Drug Manufacturers - General names. GRFS ranks #12 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	1,516,475	$381,605,769
2	LLY	ELI LILLY & Co	182,678	$219,109,491
3	GILD	Gilead Sciences, Inc.	1,458,924	$184,320,458
4	SNY	Sanofi	3,727,890	$159,031,787
5	JNJ	Johnson & Johnson	594,091	$150,881,291
6	NVS	Novartis AG	758,029	$118,798,304
7	AZN	Astrazeneca PLC	581,913	$110,342,343
8	NVO	Novo Nordisk A S	2,035,939	$97,602,915

All Filings in GRFS

Export CSV

41 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$30,939,132	4,369,934	-12.7%	Shares	Sole	2026-08-14
2026-03-31	$40,144,366	5,005,532	-29.7%	Shares	Sole	2026-05-15
2025-12-31	$66,592,149	7,122,155	+2.7%	Shares	Sole	2026-02-17
2025-09-30	$69,095,318	6,937,281	-28.2%	Shares	Sole	2025-11-14
2025-06-30	$87,394,661	9,667,551	+12.8%	Shares	Sole	2025-08-14
2025-03-31	$60,925,127	8,568,935	-8.4%	Shares	Sole	2025-05-15
2025-03-31	$255,960	36,000	-76.0%	Call	Sole	2025-05-15
2024-12-31	$1,116,000	150,000	-25.0%	Call	Sole	2025-02-14
2024-12-31	$69,582,034	9,352,424	-12.8%	Shares	Sole	2025-02-14
2024-09-30	$95,278,226	10,729,530	-22.9%	Shares	Sole	2024-11-14
2024-06-30	$87,864,516	13,924,646	-3.0%	Shares	Sole	2024-08-14
2024-06-30	$1,262,000	200,000	-55.0%	Call	Sole	2024-08-14
2024-03-31	$2,968,592	444,400	+35.2%	Call	Sole	2024-05-15
2024-03-31	$95,880,778	14,353,410	-8.8%	Shares	Sole	2024-05-15
2024-03-31	$855,040	128,000	+28.0%	Put	Sole	2024-05-15
2023-12-31	$181,944,724	15,739,163	+13.3%	Shares	Sole	2024-02-14
2023-12-31	$1,156,000	100,000	+100.0%	Put	Sole	2024-02-14
2023-09-30	$127,013,434	13,896,437	-2.1%	Shares	Sole	2023-11-14
2023-09-30	$457,000	50,000	+150.0%	Put	Sole	2023-11-14
2023-06-30	$130,014,557	14,193,729	+6.6%	Shares	Sole	2023-08-14
2023-03-31	$98,166,594	13,319,755	+40.0%	Shares	Sole	2023-05-15
2023-03-31	$2,423,256	328,800	-32.7%	Call	Sole	2023-05-15
2023-03-31	$147,400	20,000	—	Put	Sole	2023-05-15
2022-12-31	$4,149,700	488,200	+388.2%	Call	Sole	2023-02-14
2022-12-31	$80,843,797	9,511,035	+49.4%	Shares	Sole	2023-02-14
2022-09-30	$616,000	100,000	+271.7%	Call	Sole	2022-11-14
2022-09-30	$39,206,515	6,364,694	-14.5%	Shares	Sole	2022-11-14
2022-06-30	$88,417,672	7,442,565	+42.1%	Shares	Sole	2022-08-15
2022-06-30	$319,572	26,900	-89.7%	Call	Sole	2022-08-15
2022-03-31	$3,048,480	261,000	+40.9%	Call	Sole	2022-05-16
2022-03-31	$61,181,954	5,238,181	+41.9%	Shares	Sole	2022-05-16
2021-12-31	$41,441,990	3,690,293	+6.1%	Shares	Sole	2022-02-14
2021-12-31	$2,080,919	185,300	+78.3%	Call	Sole	2022-02-14
2021-09-30	$1,517,979	103,900	—	Call	Sole	2021-11-15
2021-09-30	$50,815,756	3,478,149	+109.3%	Shares	Sole	2021-11-15
2021-06-30	$28,837,938	1,662,129	+10.9%	Shares	Sole	2021-08-16
2021-03-31	$25,911,174	1,498,622	+13.5%	Shares	Sole	2021-05-17
2020-12-31	$24,339,970	1,319,955	-8.9%	Shares	Sole	2021-02-16
2020-09-30	$25,151,462	1,449,652	-12.4%	Shares	Sole	2020-11-16
2020-06-30	$30,172,626	1,654,201	-36.5%	Shares	Sole	2020-08-14
2020-03-31	$52,483,450	2,605,931	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.